How far are we? Assessing progress in hepatitis C response towards the WHO 2030 elimination goals by the civil society monitoring in 25 European countries, period 2020 to 2023.
Saved in:
| Title: | How far are we? Assessing progress in hepatitis C response towards the WHO 2030 elimination goals by the civil society monitoring in 25 European countries, period 2020 to 2023. |
|---|---|
| Authors: | Maticic M; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. prof.maticic@gmail.com.; Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana, Ljubljana, Slovenia. prof.maticic@gmail.com., Cernosa J; Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana, Ljubljana, Slovenia., Loboda C; Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana, Ljubljana, Slovenia., Tamse J; Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana, Ljubljana, Slovenia., Rigoni R; Correlation-European Harm Reduction Network, Amsterdam, The Netherlands., Duffell E; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden., Indave I; European Union Drugs Agency (EUDA), Lisbon, Portugal., Zimmermann R; Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany., Darragh L; Correlation-European Harm Reduction Network, Amsterdam, The Netherlands., Moura J; Correlation-European Harm Reduction Network, Amsterdam, The Netherlands., Leicht A; Fixpunkt E. V., Berlin, Germany., Windelinckx T; Free Clinic, Antwerp, Belgium., Jauffret-Roustide M; Cermes3 (Inserm U988/CNRS 8211/EHESS/Université de Paris), Paris, France., Schiffer K; Correlation-European Harm Reduction Network, Amsterdam, The Netherlands., Tammi T; Finnish Institute for Health and Welfare (THL), Helsinki, Finland. |
| Source: | Harm reduction journal [Harm Reduct J] 2024 Nov 20; Vol. 21 (1), pp. 203. Date of Electronic Publication: 2024 Nov 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101153624 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7517 (Electronic) Linking ISSN: 14777517 NLM ISO Abbreviation: Harm Reduct J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1477-7517 |
|---|---|
| DOI: | 10.1186/s12954-024-01115-6 |
